LCTX CapEx to Operating CF
Lineage Cell Therapeutics, Inc. Common Stock · CapEx to Operating CF

LCTX CapEx to Operating CF
Latest reported-0.76%period ending
LCTX Quarterly CapEx/OCF (0.00% → -0.76%)
Latest values, visible window
High-resolution chart · PNG
LCTX capex to operating cf history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Operating CF |
|---|---|
| -0.4505% | |
| -0.146% | |
| 0% | |
| -0.395% | |
| -1.7198% | |
| -0.4695% | |
| -4.7663% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |